Navigation Links
Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers
Date:9/12/2007

DENVER, Sept. 12 /PRNewswire/ -- Navitas Cancer Rehabilitation Centers of America, Inc. ("Navitas"), the market leader in providing integrated and comprehensive cancer rehabilitation services, is pleased to announce that it has opened a new center in Albuquerque, New Mexico. The Albuquerque Center has been established in cooperation with New Mexico Oncology Hematology Consultants, Ltd., (NMOHC) the largest independent oncology and hematology practice in the State of New Mexico. Within the Albuquerque Center, Navitas provides an integrated set of rehabilitation services designed specifically for cancer patients and survivors. These services include physical therapy, prescriptive exercise, lymphedema therapy, and psychological services, among others, all provided within a single location and in a highly personalized and integrated manner.

While initially operating at 7007 Wyoming Boulevard NE, the Center will be permanently housed within the New Mexico Cancer Center, NMOHC's largest practice location, by the fourth quarter of 2007. The Center will be able to provide services to hundreds of people undergoing cancer treatment and will employ a team of clinicians and rehabilitative specialists from various disciplines. The Albuquerque site marks the third Navitas location, joining the company's others in Denver, Colorado and Salt Lake City, Utah.

"We are excited to expand our services to the cancer patients and survivors in New Mexico," said Paul Barnes, Ph.D., President and CEO for Navitas. "Our relationship with NMOHCC gives us a great opportunity to deliver needed rehabilitative services to patients in conjunction with their cancer treatment. We believe our services will allow patients to better tolerate their cancer treatment, provide significant relief from the side effects of cancer and its treatment, and help ease the transition to cancer survivorship, both physically and emotionally."

"Navitas brings a long-needed set of rehabilitative services that will complement the cancer care that our oncologists provide, "said Barbara McAneny, M.D., CEO of NMOHCC and Board Member of the American Society of Clinical Oncology. The fact that the Navitas protocols are evidence-based and built specifically for cancer patients was a critical factor for our decision to support this program. I think the co-location in our cancer center in the fall will only increase our ability to integrate care."

About Navitas Cancer Rehabilitation Centers of America

Founded in 2003, Navitas Cancer Rehabilitation Centers of America (http://www.navitasinc.com) developed an evidence-based approach to providing rehabilitation and supportive therapies to people with cancer. Navitas provides these services on a free-standing basis as well as through community-based and hospital-based oncology centers and practices. The Navitas vision is to make supportive and rehabilitation services a standard component of the cancer treatment plan through the development of a robust, multi-disciplinary clinical program and demonstrated outcomes for patients and physicians. Navitas is headquartered in Denver, Colorado.

http://www.navitasinc.com

About The New Mexico Cancer Center

The physicians of the New Mexico Oncology Hematology Consultants, Ltd comprise NMOHCC. It is Albuquerque's first freestanding cancer treatment facility and provides multidisciplinary cancer treatments, including chemotherapy and radiation. NMOHCC is committed to bringing state-of-the-art technology and the latest therapies to cancer patients throughout New Mexico. The medical team practices in several regions of the state, including Albuquerque, Silver City, Farmington, Ruidoso, and Gallup.

http://www.nmcancercenter.com

Media Contact:

Paul Barnes

303-865-7840

pbarnes@navitasinc.com


'/>"/>
SOURCE Navitas Cancer Rehabilitation Centers of America, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First global SARS meet opens
2. Cancer Drug Opens Arteries
3. Ranbaxy opens Drug discovery centre in Gurgaon
4. Delhi Hospital Opens Up Avenues For Computer-Aided Knee Replacement
5. Cancer Hospice Opens New In-patient Unit
6. Center for Celiac Disease Opens
7. Review Opens Bag of Tricks for Reducing Pain from Children’s Shot
8. Apollo Eyes Expansion in Kolkata, Opens Ayurveda Clinic
9. Largest Ever African HIV Vaccine Trial Opens in South Africa
10. Apollo Opens Blood Cancer Clinic in Kolkata
11. China Opens Doors For Foreign Investments In Hospitals Care System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/21/2017)... ... September 21, 2017 , ... Promotional Communication:, ... http://www.fdanews.com/products/54818-promotional-communication      , In the competitive world of drug and device marketing and ... compliance with FDA rules. , The FDA has issued two draft guidances that ...
(Date:9/21/2017)... ... September 21, 2017 , ... In addition to sticking with ... more holistic approach and use natural alternatives for all house cleaning products, disinfectants, ... USDA guaranteeing that, the new line of essential oils, are all 100% organic ...
(Date:9/21/2017)... ... September 21, 2017 , ... Japanese Zen artist couple, ... Revolution” on 6th, 7th and 8th October at Miranda Kuo Gallery on Lower East ... pieces, such as Zen Kodo mat. Wanderlust , one of the largest US ...
(Date:9/21/2017)... ... September 21, 2017 , ... ... serving communities in northern Alabama and Georgia, is embarking on an extended charity ... utilizing modern early detection methods. , US Breast Cancer statistics show that ...
(Date:9/20/2017)... ... September 20, 2017 , ... Collins Concrete ... for clients that rely on safety and cleanliness. This unique flooring system uses ... has been used for centuries for its antimicrobial properties. Unlike antibiotics, which kill ...
Breaking Medicine News(10 mins):
(Date:9/12/2017)... , Sept. 12, 2017   EcoVadis , the leading platform ... published the first annual edition of its Global CSR Risk and Performance ... evaluated by EcoVadis, based on Scorecard Ratings that analyzed nearly 800,000 data ... ... ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... Ind. , Sept. 7, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Global Healthcare Conference at the Grand Hyatt hotel in ... 11, 2017 at 11:40 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
Breaking Medicine Technology: